Xu fei
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer (NCT02910050) | Xu fei | 2016-01-01 |
Track Xu fei automatically
Every clearance here is in the API, with alerts when new ones post.